Pioglitazone and PPAR-γ modulating treatment in hypertensive and type 2 diabetic patients after ischemic stroke: a national cohort study

BACKGROUND AND AIM: Peroxisome proliferator-activated receptor-γ (PPAR-γ) modulating treatment may have cardiovascular benefits in type 2 diabetes mellitus (T2DM) patients after ischemic stroke (IS). However, whether there are additional benefits from intensive PPAR-γ modulating treatments in Asian...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cardiovasc Diabetol
Auteurs principaux: Liu, Chi-Hung, Lee, Tsong-Hai, Lin, Yu-Sheng, Sung, Pi-Shan, Wei, Yi-Chia, Li, Yan-Rong
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2020
Sujets:
Original Investigation
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6945719/
https://ncbi.nlm.nih.gov/pubmed/31910836
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-019-0979-x
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires